Cofco Historical Balance Sheet

000930 Stock

5.78 0.04 0.69%

Trend analysis of Cofco Biochemical Anhui balance sheet accounts such as Other Current Liab of 28.7 M, Total Current Liabilities of 4.9 B or Total Stockholder Equity of 11 B provides information on Cofco Biochemical's total assets, liabilities, and equity, which is the actual value of Cofco Biochemical Anhui to its prevalent stockholders. By breaking down trends over time using Cofco Biochemical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Cofco Biochemical Anhui latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cofco Biochemical Anhui is a good buy for the upcoming year.

Cofco Biochemical Inventory

1.64 Billion

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cofco Biochemical Anhui. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Cofco Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Cofco Biochemical Anhui at a specified time, usually calculated after every quarter, six months, or one year. Cofco Biochemical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cofco Biochemical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cofco currently owns. An asset can also be divided into two categories, current and non-current.

Cofco Biochemical Balance Sheet Chart

At present, Cofco Biochemical's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Cash is expected to grow to about 1.6 B, whereas Total Assets are forecasted to decline to about 9.9 B.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity Accounts Payable Non Currrent Assets Other

Total Assets

Total assets refers to the total amount of Cofco Biochemical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cofco Biochemical Anhui books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Cofco Biochemical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cofco Biochemical Anhui are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Accounts Payable

An accounting item on the balance sheet that represents Cofco Biochemical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Cofco Biochemical Anhui are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Most accounts from Cofco Biochemical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Cofco Biochemical Anhui current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cofco Biochemical Anhui. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	1.4B	952.6M	30.2M	28.7M
Total Assets	18.1B	18.1B	16.6B	9.9B

Other Current Liab Total Assets

Cofco Biochemical balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Total Liab	Common Stock	Property Plant Equipment	Other Liab	Other Assets	Intangible Assets	Short Term Investments	Net Tangible Assets	Other Stockholder Equity	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total
Total Assets		0.34	0.46	0.91	0.74	0.79	0.58	-0.31	0.6	0.94	0.4	0.9	0.85	0.83	0.54	0.17	0.86	-0.52	0.89	0.87	0.84	0.78	0.84	0.73	0.85	0.93
Other Current Liab	0.34		0.9	0.15	0.06	0.71	-0.02	0.14	0.88	0.49	0.91	0.47	0.16	0.55	-0.09	0.44	0.49	-0.28	0.27	0.47	0.56	0.48	0.42	0.71	0.29	0.25
Total Current Liabilities	0.46	0.9		0.32	0.16	0.79	0.24	-0.03	0.83	0.64	0.98	0.59	0.39	0.71	0.16	0.43	0.62	-0.45	0.45	0.63	0.69	0.67	0.64	0.87	0.48	0.39
Total Stockholder Equity	0.91	0.15	0.32		0.79	0.73	0.8	-0.5	0.48	0.82	0.27	0.72	0.94	0.78	0.69	0.01	0.8	-0.47	0.94	0.89	0.85	0.87	0.77	0.7	0.94	0.97
Retained Earnings	0.74	0.06	0.16	0.79		0.62	0.46	-0.3	0.31	0.75	0.14	0.43	0.62	0.69	0.55	-0.34	0.45	-0.37	0.74	0.65	0.59	0.57	0.46	0.48	0.61	0.69
Accounts Payable	0.79	0.71	0.79	0.73	0.62		0.52	-0.27	0.88	0.87	0.76	0.7	0.69	0.89	0.36	0.22	0.83	-0.43	0.81	0.89	0.92	0.88	0.76	0.92	0.79	0.77
Cash	0.58	-0.02	0.24	0.8	0.46	0.52		-0.55	0.37	0.48	0.13	0.42	0.87	0.59	0.74	0.2	0.63	-0.43	0.81	0.75	0.74	0.8	0.57	0.56	0.86	0.76
Long Term Debt	-0.31	0.14	-0.03	-0.5	-0.3	-0.27	-0.55		0.0	-0.27	-0.09	-0.11	-0.4	-0.22	-0.53	0.02	-0.4	-0.23	-0.56	-0.52	-0.47	-0.52	-0.44	-0.35	-0.58	-0.53
Net Receivables	0.6	0.88	0.83	0.48	0.31	0.88	0.37	0.0		0.66	0.79	0.63	0.51	0.75	0.16	0.46	0.71	-0.42	0.59	0.72	0.81	0.73	0.56	0.82	0.6	0.57
Inventory	0.94	0.49	0.64	0.82	0.75	0.87	0.48	-0.27	0.66		0.61	0.87	0.75	0.85	0.45	0.17	0.83	-0.49	0.83	0.85	0.83	0.79	0.87	0.85	0.79	0.84
Other Current Assets	0.4	0.91	0.98	0.27	0.14	0.76	0.13	-0.09	0.79	0.61		0.52	0.29	0.63	0.07	0.37	0.57	-0.3	0.39	0.58	0.65	0.63	0.62	0.86	0.43	0.35
Total Liab	0.9	0.47	0.59	0.72	0.43	0.7	0.42	-0.11	0.63	0.87	0.52		0.75	0.7	0.39	0.38	0.86	-0.56	0.68	0.73	0.71	0.68	0.88	0.73	0.73	0.8
Common Stock	0.85	0.16	0.39	0.94	0.62	0.69	0.87	-0.4	0.51	0.75	0.29	0.75		0.78	0.73	0.18	0.82	-0.66	0.88	0.86	0.83	0.87	0.76	0.69	0.93	0.92
Property Plant Equipment	0.83	0.55	0.71	0.78	0.69	0.89	0.59	-0.22	0.75	0.85	0.63	0.7	0.78		0.57	0.09	0.72	-0.66	0.86	0.9	0.9	0.86	0.71	0.83	0.78	0.77
Other Liab	0.54	-0.09	0.16	0.69	0.55	0.36	0.74	-0.53	0.16	0.45	0.07	0.39	0.73	0.57		-0.08	0.4	-0.55	0.63	0.57	0.53	0.58	0.47	0.41	0.65	0.61
Other Assets	0.17	0.44	0.43	0.01	-0.34	0.22	0.2	0.02	0.46	0.17	0.37	0.38	0.18	0.09	-0.08		0.47	-0.24	0.11	0.2	0.27	0.21	0.3	0.3	0.22	0.14
Intangible Assets	0.86	0.49	0.62	0.8	0.45	0.83	0.63	-0.4	0.71	0.83	0.57	0.86	0.82	0.72	0.4	0.47		-0.43	0.81	0.87	0.87	0.85	0.87	0.82	0.88	0.87
Short Term Investments	-0.52	-0.28	-0.45	-0.47	-0.37	-0.43	-0.43	-0.23	-0.42	-0.49	-0.3	-0.56	-0.66	-0.66	-0.55	-0.24	-0.43		-0.4	-0.43	-0.43	-0.43	-0.37	-0.41	-0.42	-0.39
Net Tangible Assets	0.89	0.27	0.45	0.94	0.74	0.81	0.81	-0.56	0.59	0.83	0.39	0.68	0.88	0.86	0.63	0.11	0.81	-0.4		0.97	0.94	0.92	0.78	0.77	0.95	0.95
Other Stockholder Equity	0.87	0.47	0.63	0.89	0.65	0.89	0.75	-0.52	0.72	0.85	0.58	0.73	0.86	0.9	0.57	0.2	0.87	-0.43	0.97		0.99	0.97	0.83	0.88	0.95	0.93
Deferred Long Term Liab	0.84	0.56	0.69	0.85	0.59	0.92	0.74	-0.47	0.81	0.83	0.65	0.71	0.83	0.9	0.53	0.27	0.87	-0.43	0.94	0.99		0.97	0.8	0.91	0.93	0.89
Long Term Investments	0.78	0.48	0.67	0.87	0.57	0.88	0.8	-0.52	0.73	0.79	0.63	0.68	0.87	0.86	0.58	0.21	0.85	-0.43	0.92	0.97	0.97		0.82	0.92	0.95	0.89
Short Long Term Debt	0.84	0.42	0.64	0.77	0.46	0.76	0.57	-0.44	0.56	0.87	0.62	0.88	0.76	0.71	0.47	0.3	0.87	-0.37	0.78	0.83	0.8	0.82		0.86	0.84	0.84
Total Current Assets	0.73	0.71	0.87	0.7	0.48	0.92	0.56	-0.35	0.82	0.85	0.86	0.73	0.69	0.83	0.41	0.3	0.82	-0.41	0.77	0.88	0.91	0.92	0.86		0.81	0.76
Short Term Debt	0.85	0.29	0.48	0.94	0.61	0.79	0.86	-0.58	0.6	0.79	0.43	0.73	0.93	0.78	0.65	0.22	0.88	-0.42	0.95	0.95	0.93	0.95	0.84	0.81		0.97
Non Current Assets Total	0.93	0.25	0.39	0.97	0.69	0.77	0.76	-0.53	0.57	0.84	0.35	0.8	0.92	0.77	0.61	0.14	0.87	-0.39	0.95	0.93	0.89	0.89	0.84	0.76	0.97

Click cells to compare fundamentals

Cofco Biochemical Account Relationship Matchups

Cofco Biochemical balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	17.2B	20.5B	18.1B	18.1B	16.6B	9.9B
Other Current Liab	2.5B	1.3B	1.4B	952.6M	30.2M	28.7M
Total Current Liabilities	6.5B	9.3B	5.6B	5.2B	5.1B	4.9B
Total Stockholder Equity	9.8B	10.4B	11.4B	12.1B	10.5B	11.0B
Retained Earnings	1.3B	1.8B	2.8B	3.2B	1.4B	824.6M
Accounts Payable	854.8M	845.8M	920.2M	919.6M	766.5M	615.6M
Cash	700.5M	662.3M	1.1B	1.0B	1.5B	1.6B
Long Term Debt	274.7M	189.7M	406.4M	191.3M	165.6M	157.4M
Net Receivables	1.4B	734.5M	1.5B	1.1B	1.0B	742.2M
Inventory	2.8B	5.0B	4.1B	3.8B	2.5B	1.6B
Other Current Assets	1.8B	2.9B	982.0M	1.3B	485.7M	819.8M
Total Liab	7.0B	9.7B	6.3B	5.6B	5.7B	5.1B
Property Plant Equipment	8.2B	8.5B	8.5B	8.6B	9.9B	5.5B
Other Liab	108.3M	125.8M	169.6M	189.2M	217.6M	228.4M
Other Assets	522.8M	354.3M	400.0M	306.4M	352.3M	337.1M
Intangible Assets	823.9M	852.7M	629.7M	610.6M	602.7M	632.8M
Net Tangible Assets	8.6B	9.2B	10.4B	11.1B	12.8B	7.4B
Other Stockholder Equity	683.1M	651.2M	616.9M	692.8M	796.8M	521.5M
Deferred Long Term Liab	26.7M	27.2M	22.2M	25.2M	29.0M	20.5M
Short Long Term Debt	2.5B	6.6B	2.8B	2.9B	3.2B	3.3B
Total Current Assets	6.7B	9.9B	7.6B	7.7B	6.0B	7.5B
Non Current Assets Total	10.4B	10.6B	10.4B	10.4B	10.5B	9.8B
Non Currrent Assets Other	121.0M	198.8M	(86.5M)	109.4M	80.0M	95.1M
Non Current Liabilities Total	412.7M	359.3M	712.9M	427.3M	562.5M	499.8M
Net Debt	2.1B	6.1B	2.1B	2.0B	1.9B	2.4B
Net Invested Capital	12.6B	17.2B	14.6B	15.2B	13.8B	14.6B
Net Working Capital	186.6M	578.0M	2.0B	2.5B	893.5M	700.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Other Information on Investing in Cofco Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cofco Historical Balance Sheet

Cofco Biochemical Inventory

1.64 Billion

About Cofco Balance Sheet Analysis

Cofco Biochemical Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Accounts Payable

Non Currrent Assets Other

Cofco Biochemical balance sheet Correlations

Cofco Biochemical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cofco Biochemical balance sheet Accounts

Also Currently Popular

Other Information on Investing in Cofco Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Deferred Long Term Liab	+ 0.99	Other Stockholder Equity
Other Current Assets	+ 0.98	Total Current Liabilities
Non Current Assets Total	+ 0.97	Total Stockholder Equity
Other Stockholder Equity	+ 0.97	Net Tangible Assets
Long Term Investments	+ 0.97	Other Stockholder Equity
Long Term Investments	+ 0.97	Deferred Long Term Liab

Short Term Investments	- 0.66	Property Plant Equipment
Short Term Investments	- 0.66	Common Stock
Short Term Debt	- 0.58	Long Term Debt
Short Term Investments	- 0.56	Total Liab
Net Tangible Assets	- 0.56	Long Term Debt
Short Term Investments	- 0.55	Other Liab